Profile
| Role | Director |
|---|---|
| Notability | 30/100 |
Board memberships
- Madrigal Pharmaceuticals, Inc.
Updated Jul 16, 2026
Brennan Daniel J. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-18 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | A — Grant or award | 404 | $0.00 | |
| 2026-02-28 | WAT | WATERS CORP /DE/ | A — Grant or award | 23 | $0.00 | |
| 2026-01-05 | WAT | WATERS CORP /DE/ | A — Grant or award | 307 | $0.00 | |
| 2025-08-01 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | A — Grant or award | 967 | $0.00 |
Brennan Daniel J. is a corporate insider — currently tracked as Director of MADRIGAL PHARMACEUTICALS, INC. (MDGL). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Brennan Daniel J. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.